We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$551M
AUM Growth
-$18M
Cap. Flow
-$3.48M
Cap. Flow %
-0.63%
Top 10 Hldgs %
36.14%
Holding
161
New
13
Increased
35
Reduced
76
Closed
17

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$6.58M
2
HAL icon
Halliburton
HAL
+$2.97M
3
DAN icon
Dana Inc
DAN
+$2.79M
4
ELAN icon
Elanco Animal Health
ELAN
+$2.72M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.68M

Sector Composition

Rank Sector Weight
1 Industrials 25.67%
2 Healthcare 25.14%
3 Technology 17.1%
4 Utilities 7.21%
5 Energy 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAMP
51
DELISTED
CalAmp Corp.
CAMP
$3.15M 0.57%
11,873
+7,138
+151% +$1.76M
EWS icon
52
iShares MSCI Singapore ETF
EWS
$1.04B
$2.8M 0.51%
120,800
-1,325
-1% -$31.4K
EAF icon
53
GrafTech
EAF
$175M
$2.65M 0.48%
20,716
+233
+1% +$27.7K
DAN icon
54
Dana Inc
DAN
$2.9B
$2.6M 0.47%
+179,800
New +$2.79M
SWK icon
55
Stanley Black & Decker
SWK
$14.3B
$2.54M 0.46%
17,600
-900
-5% -$127K
ELAN icon
56
Elanco Animal Health
ELAN
$13.2B
$2.41M 0.44%
+90,800
New +$2.72M
ANET icon
57
Arista Networks
ANET
$227B
$2.33M 0.42%
+156,000
New +$2.41M
AMGN icon
58
Amgen
AMGN
$208B
$2.25M 0.41%
11,622
HZNP
59
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.17M 0.39%
+79,552
New +$2.06M
ASTE icon
60
Astec Industries
ASTE
$1.16B
$2M 0.36%
64,400
-29,250
-31% -$890K
GE icon
61
GE Aerospace
GE
$374B
$1.94M 0.35%
43,594
-1,560
-3% -$73.3K
AAPL icon
62
Apple
AAPL
$4.54T
$1.92M 0.35%
34,356
-18,116
-35% -$947K
GOOGL icon
63
Alphabet (Google) Class A
GOOGL
$4.36T
$1.92M 0.35%
31,480
+100
+0.3% +$5.92K
BAX icon
64
Baxter International
BAX
$13.5B
$1.89M 0.34%
21,576
-33,850
-61% -$2.89M
NBL
65
DELISTED
Noble Energy, Inc.
NBL
$1.86M 0.34%
82,800
-2,200
-3% -$49K
DOW icon
66
Dow Inc
DOW
$21.9B
$1.74M 0.32%
36,592
+4,610
+14% +$216K
VIAV icon
67
Viavi Solutions
VIAV
$9.12B
$1.66M 0.3%
118,225
-118,975
-50% -$1.69M
ESBK
68
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$1.6M 0.29%
113,855
-129,166
-53% -$1.91M
VOO icon
69
Vanguard S&P 500 ETF
VOO
$979B
$1.53M 0.28%
5,615
-88
-2% -$23.9K
CNDT icon
70
Conduent
CNDT
$244M
$1.41M 0.26%
225,870
+197,565
+698% +$1.53M
AGG icon
71
iShares Core US Aggregate Bond ETF
AGG
$137B
$1.36M 0.25%
12,020
-355
-3% -$39.9K
CTVA icon
72
Corteva
CTVA
$52.6B
$1.35M 0.25%
48,291
+28,174
+140% +$815K
SBNY
73
DELISTED
Signature Bank
SBNY
$1.35M 0.24%
11,300
-2,150
-16% -$260K
PBW icon
74
Invesco WilderHill Clean Energy ETF
PBW
$407M
$1.29M 0.23%
44,230
-320
-0.7% -$9.59K
ALC icon
75
Alcon
ALC
$33.6B
$1.28M 0.23%
22,022
-7,840
-26% -$470K

Similar funds

John G. Ullman & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, John G. Ullman & Associates held 161 positions worth $551M, down 3.2% from $569M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

John G. Ullman & Associates's Q3 2019 filing shows 13 new, 35 increased, 76 reduced and 17 closed positions. Its largest new stake was Dana Inc: 179,800 shares worth $2.6M. The largest sale was Evergy, an estimated $9.16M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

  • John G. Ullman & Associates's largest Q3 2019 buy was Dana Inc: 179,800 shares worth $2.6M.
  • John G. Ullman & Associates added most to 3M in Q3 2019, an estimated $6.58M increase.
  • John G. Ullman & Associates's biggest Q3 2019 reduction was ExxonMobil, cutting an estimated $5.21M.
  • John G. Ullman & Associates fully exited Evergy in Q3 2019, selling an estimated $9.16M.
  • John G. Ullman & Associates's ten largest holdings make up 36% of its $551M portfolio in Q3 2019.
  • John G. Ullman & Associates opened 13 new positions and closed 17 in Q3 2019.
  • John G. Ullman & Associates's portfolio value fell 3.2% quarter-over-quarter to $551M.

Based on John G. Ullman & Associates's 13F filing for Q3 2019, filed 21 Oct 2019.